In Very High-Risk Patients with Vascular Disease, Evolocumab Slightly Reduces Nonfatal MI But Not Mortality

Mark H. Ebell

Research output: Contribution to journalArticle

Original languageEnglish (US)
Number of pages1
JournalAmerican family physician
Volume96
Issue number7
Publication statusPublished - Oct 1 2017

ASJC Scopus subject areas

  • Family Practice

Cite this